Zobrazeno 1 - 10
of 6 328
pro vyhledávání: '"sclc."'
Autor:
Ying Wang, Jingying Nong, Baohua Lu, Yuan Gao, Mingming Hu, Cen Chen, Lina Zhang, Jinjing Tan, Xiaomei Yang, Peter Ping Lin, Xingsheng Hu, Tongmei Zhang
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 4, Pp 335-345 (2024)
Background: Small cell lung cancer (SCLC) is a highly aggressive disease characterized by early metastasis. Aneuploid CD31- disseminated tumor cells (DTCs) and CD31+ disseminated tumor endothelial cells (DTECs) residing in the bone marrow are general
Externí odkaz:
https://doaj.org/article/7efce40ac5a54bfb9cf4bcefc7759d51
Autor:
Giggie, John M., author
Publikováno v:
Bloody Tuesday : The Untold Story of the Struggle for Civil Rights in Tuscaloosa, 2024, ill.
Externí odkaz:
https://doi.org/10.1093/oso/9780197766668.003.0006
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 15, Pp 149-159 (2024)
Joo Sung Shim,1 Youhyun Kim,1 Taeho Yuh,1 Jii Bum Lee,2 Hye Ryun Kim,2 Min Hee Hong,2 Byoung Chul Cho,2 Sun Min Lim2 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Division of Medical Oncology, Dep
Externí odkaz:
https://doaj.org/article/996fcd206b2a4c2b8df505c9dd5834ec
Autor:
Qing Hou, Yu Liang, Ningning Yao, Jianting Liu, Xin Cao, Shuangping Zhang, Lijuan Wei, Bochen Sun, Peixin Feng, Wenjuan Zhang, Jianzhong Cao
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Though several nomograms have been established to predict the survival probability of patients with small-cell lung cancer (SCLC), none involved enough variables. This study aimed to construct a novel prognostic nomogram and compa
Externí odkaz:
https://doaj.org/article/d4003495c57a4268b257e8bc2792c38c
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Backrgound Merkel cell carcinoma (MCC) is a rare, aggressive primary cutaneous neuroendocrine carcinoma, frequently associated with clonal Merkel cell polyomavirus integration. MCC can pose significant diagnostic challenges due to its divers
Externí odkaz:
https://doaj.org/article/454cba4a3113406a80c8c8b5880d9273
Autor:
Mingjie Yu, Ping Wang
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Background Small Cell Lung Cancer (SCLC) presents a significant clinical challenge due to its aggressive nature and the need for effective biomarkers for treatment monitoring. This study aimed to compare ProGRP and CEA as serological markers
Externí odkaz:
https://doaj.org/article/298b5589b81c4f9194438535a0f6906e
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract Small cell lung cancer (SCLC) constitutes approximately 10% to 15% of all lung cancer diagnoses and represents a pressing global public health challenge due to its high mortality rates. The efficacy of conventional treatments for SCLC is sub
Externí odkaz:
https://doaj.org/article/d2781a33d6bb4c63b727c6ec554d6bd0
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Delta-like ligand 3 (DLL3) is highly expressed on the cell surface of small cell lung cancer (SCLC), one of the most lethal malignancies, but minimally or not in normal tissues, making it an attractive target for SCLC. However, no
Externí odkaz:
https://doaj.org/article/598fe1eb274c48ac83117a0ba832d06d
Autor:
Laura Moliner, MD, Núria Zellweger, MSc, Sabine Schmid, MD, Martina Bertschinger, MD, Christine Waibel, MD, Ferdinando Cerciello, MD, PhD, Patrizia Froesch, MD, Michael Mark, MD, Adrienne Bettini, MD, Pirmin Häuptle, MD, Veronika Blum, MD, Lisa Holer, MSc, Stefanie Hayoz, PhD, Martin Früh, MD, Samreen Ahmed, FRCP, MD, MBBS, MSc, Shradha Bhagani, MD, Nicola Steele, MD, Hannah-Leigh Gray, BSc, Stephen D. Robinson, MD, Michael Davidson, MD (Res), Samantha Cox, MD, MSc, MBBCh, Taha Khalid, MD, Tom R. Geldart, MD, Luke Nolan, FRCS, PhD, Deborah C. Scott, MBChB (MRCP), Lindsay Hennah, MD, Tom Newsom-Davis, MD, PhD, Emma Rathbone, MD, PhD, Catherine Handforth, MD, Arshi Denton, MD, Shairoz Merchant, PhD, Fiona Blackhall, MD, PhD, Laetitia A. Mauti, MD, Raffaele Califano, MD, Sacha I. Rothschild, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 6, Iss 1, Pp 100744- (2025)
Introduction: SCLC is characterized by aggressiveness and limited treatment options, especially in extensive-stage SCLC (ES-SCLC). Immunotherapy added to the platinum-etoposide combination has recently become standard in this setting. This retrospect
Externí odkaz:
https://doaj.org/article/4fc33687ab8d4162bfd96a7cd9362df2
Publikováno v:
Cancer Medicine, Vol 13, Iss 23, Pp n/a-n/a (2024)
ABSTRACT Objectives Extensive‐stage small cell lung cancer (ES‐SCLC) suffering from brain metastases (BM) has a poor prognosis and lacks effective treatment selection. In this study, we explored the efficacy and safety of combination treatment of
Externí odkaz:
https://doaj.org/article/0b46619891394bb8b878a2d9bc52c7ee